D. E. Shaw & Co., Inc. Sio Gene Therapies Inc. Transaction History

D. E. Shaw & Co., Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.25 - $0.73 $5,757 - $16,810	23,028 New	23,028 $8,000
Q2 2021 Aug 16, 2021	SELL	$2.07 - $2.89 $342,036 - $477,529	-165,235 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$2.34 - $3.44 $386,649 - $568,408	165,235 New	165,235 $431,000

147K

Ticker SIOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,975,200
Description
Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical S...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.